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This study  investigated  the  functional  diversity  of Lactobacillus  helveticus  KLDS1.8701  by carrying  out  a
whole-genome  sequence  analyses  of L.  helveticus  KLDS1.8701.  L.  helveticus  KLDS1.8701  strain  was  isolated
from  traditional  sour  milk  in Sinkiang  of China  with  desirable  probiotic  properties.  Here  we  report  thevailable online 22 August 2015
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complete  genome  sequence  of  this  organism  and  its  genetic  basis  for adhesion,  exopolysaccharides  (EPS)
production,  acid  and  bile  tolerance,  bacteriocin  production  and  immune  system  against  bacteriophage.
© 2015  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).acteriocin
Lactobacillus helveticus is present in several fermented foods
nd also is used as a probiotics with many health-promoting
roperties (Champagne et al., 2010). Being generally recognized
s safe (GRAS), strains of this species emerge as an adjunct cul-
ure for diverse cheeses with highly efﬁcient proteolytic activity.
hese strains also produce peptides with a biological function,
or instance, peptides possessing an inhibitory activity on the
ngiotensin converting enzyme (Giraffa, 2014). Clinical trials have
emonstrated the effect of L. helveticus against diseases such as
ancer and intestinal inﬂammation (Prajapati et al., 2011). The
. helveticus KLDS1.8701 strain was originally isolated from tra-
itional sour milk in Sinkiang of China. In a previous in vitro
astrointestinal tract tolerance test, it was reported that L. hel-
eticus KLDS1.8701 could resist simulated gastric juice, intestinal
uice and bile salt, with the number of viable bacteria remained
t more than 1 × 106 CFU/mL after 3 h, indicating that this strain
ould reach the intestine in a viable state. Lymphocyte prolifera-
ion test showed that it could accelerate the proliferation of spleen
ells in a dose-dependent manner (Wang et al., 2013). An in vivo
tudy using animal model suggests that this strain could regulate
he imbalance of gut microbes in diseased mice, and improve the
ntestinal mucosal immune system by stimulating cytokines and
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/).SIgA production, thus exerting a therapeutic effect on diarrhea dis-
ease (Wang et al., 2014). These results offer a theoretical basis for
the development of drugs and a potential probiotic strain. Today,
it has been used in the production of lactein tablets by a pharma-
ceutical factory in Heilongjiang province. Lactein is normally used
in the treatment of indigestion, enteritis, children’s diarrhea and
other diseases.
To generate genomic insights into the functional diversity of L.
helveticus KLDS1.8701, we performed the whole-genome sequence
of L. helveticus KLDS1.8701 using a strategy of Illumina paired-end
sequencing technology. Long-insert (5 kb), medial-insert (2.5 kb)
and short-insert (500 bp) libraries were constructed for the Illu-
mina Hiseq 2000 platform. A total of 784 M clean data was
generated from 3 libraries giving 372-fold coverage of the genome,
De novo assembly was  conducted by SOAPdenovo 2.0 (Luo et al.,
2012), which resulted 3 scaffolds with an N50Contig length of
130,432 bp long, there are only 2 gaps between scaffolds, then gaps
were ﬁlled by sequencing PCR products using an ABI 3730 capil-
lary sequence. Gene annotation was  managed by NCBI Prokaryotic
Genome annotation Pipeline. CRIPER ﬁnder (http://crispr.u-psud.
fr/Server/), was  used for searching CRISPR/Cas system. Genes
potentially involved in the biosynthesis of bacteriocins were iden-
tiﬁed using BAGEL (http://bagel2.molgenrug.nl/).
The complete genome of L. helveticus KLDS1.8701 is composed of
a circular chromosome of 2,096,031 bp with a GC content of 37% and
a plasmid of 10,600 bp with a GC content of 34%. The chromosome
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table  1
General genome features of Lactobacillus helveticus KLDS4.0325.
Feature Chromosome Plasmid
Size [bp] 2,096,031 10,600
GC  content [%] 36.88% 34%
Predicted genes 2164 13
Protein coding genes (CDSs) 1763 10
Pseudogenes 327 3
rRNA operons 12 0
tRNAs 61 0
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GenBank accession CP009907.1 CP009908.1
f L. helveticus KLDS1.8701 contains 1763 CDSs, 77 RNAs and 327
seudogenes (Table 1).
We  compared the genome of L. helveticus KLDS1.8701 obtained
n this study with publicly available complete genome sequences of
. helveticus strains DPC4571 (GenBank accession no. NC 10080.1)
Callanan et al., 2008), H10 (GenBank accession no. NC 17467.1)
Zhao et al., 2011), R0052 (GenBank accession no. NC 18528.1)
Tompkins et al., 2012), CNRZ32 (GenBank accession no. NC
1744.1) (Broadbent et al., 2013), H9 (GenBank accession no.
P002427) (Chen et al., 2015), MB2-1 (GenBank accession no.
P011386) (Li et al., 2015). L. helveticus KLDS1.8701 has more
ucus-binding proteins (HUO 04880, HUO 07225, HUO 07230,
UO 07235) than other sequenced L. helveticus,  indicating that
his strain may  have superiority to colonize in the intestinal tract
nd interact with the gut microorganisms as probiotics. In addi-
ion, it also has a disrupted gene encoded adhesion (HUO 04755).
he KLDS1.8701 genome carries an EPS cluster including 13
enes. HUO 10125 and HUO 10110 encode for biosynthesis reg-
lation, HUO 10120 and HUO 10115 encode for determining the
hain length, HUO 10105, HUO 10100, HUO 10095, HUO 10085,
UO 10080, HUO 10075, HUO 10050 encode for glycosyltrans-
erases, HUO 10090 encodes for polymerization event, HUO 10040
ncodes for exporting EPS. As compared to other sequenced
enomes, HUO 10110, HUO 10090, HUO 10085, HUO 10050,
UO 10040 are unique genes in this cluster, they may  endue EPS
f L. helveticus KLDS1.8701 a distinctive characteristic. We  have
reviously reported the ability of L. helveticus KLDS1.8701 to sur-
ive simulated gastric juice (pH 2) and Intestinal juice (pH 7.5),
 g/kg bile salts (Wang et al., 2013). Regarding how genetic ele-
ents of L. helveticus KLDS1.8701 contributes to acid tolerance,
ur results showed that L. helveticus KLDS1.8701 possesses pro-
on motive force F1F0ATPase subunits (HUO 00815, HUO 04975,
UO 06740, HUO 08125 to HUO 08160) to actively remove
rotons from the cytoplasm. Furthermore, Na+/H+ antiporters
HUO 00630, HUO 06055, HUO 06835, HUO 09320) and H+–K+-
xchanging ATPase (HUO 08750) also make contributions to
egulate pH of intracellular. Surprisingly, L. helveticus KLDS1.8701
isplayed a lack of bile salt hydrolases and conjugated bile acid
ydrolases genes.  There is a gene encoded cyclopropane-fatty-
cyl-phospholipid synthase (HUO 05315) in the genome of L.
elveticus KLDS1.8701 to establish its ability to tolerate bile acid.ology 212 (2015) 90–91 91
Detailed analysis of the genome revealed four genes (HUO 02275,
HUO 03195, HUO 06670, HUO 07285) encoding for bacteriocin,
especially HUO 07285, which can’t ﬁnd its homology, may endow
some competitive advantages for bacteria when producing lactein
in commercial use, 3CRISPR/Cas loci and the restriction modiﬁca-
tion system (the Type I, Type II and Type III) were identiﬁed in the
genome of L. helveticus KLDS1.8701, these data suggest that this
strain may  own a better defense system against bacteriophages,
therefore, this strain may  be suitable for industrial production.
The complete genome chromosome and plasmid sequence
have been deposited in GenBank database with accession num-
ber CP009907.1 and CP009908.1, respectively. This strain has been
deposited at the China General Microbiological Culture Collection
Center (CGMCC No.6639).
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